Meet with Allucent at the CNS Summit!
Join Allucent at the CNS Summit in Boston, where life sciences leaders gather for collaborative discussions, networking, and insights shaping the future of clinical development. Our ACE Therapeutic Strategy Head, Neuroscience, Roberta Anderson, will be attending and welcomes the opportunity to connect with peers across the CNS community and beyond.
If you’d like to meet with Roberta at the CNS Summit to learn more about our neuroscience and drug development expertise, please schedule a meeting.
Fill out the form to schedule a meeting.
Attendees
Roberta Anderson, PhD, ACE Therapeutic Strategy Head, Neuroscience, Allucent
Roberta Anderson, PhD, is the ACE Therapeutic Strategy Head, Neuroscience at Allucent and brings nearly 30 years of clinical development experience with deep specialization in neuroscience. She has a broad range of indications experience across neurological disorders, including Alzheimer’s disease, stroke, sleep disorders, and Tourette’s Syndrome. She also has strong regulatory expertise guiding complex submissions and approvals (FDA INDs, Health Canada CTAs, SPA), with experience across multiple phases of development.
Share This
